A PHASE IV, MULTICENTER, OPEN-LABEL STUDY OF THE IMMUNOG

Project: Research project

Project Details

Description

A PHASE IV, MULTICENTER, OPEN-LABEL STUDY OF THE IMMUNOGENICITY OF NUTROPIN AQ V1.1 [SOMATROPIN (rDNA ORIGIN) INJECTION] ADMINISTERED DAILY TO NA??VE GROWTH HORMONEDEFICIENT CHILDREN
StatusFinished
Effective start/end date1/1/1512/31/18

Funding

  • Genentech Inc.